Brainreader Neuroreader®

Automatic labelling, visualization and volumetric quantification of segmentable brain structures from MRI images.

Brainreader-header-768x512

Overview

Brainreader’s flagship product, Neuroreader®, is an FDA cleared and CE marked software-based assessment tool that can detect abnormal brain patterns in MRI scans.

  • Visualizes and quantifies atrophies of up to 83 brain volumes from Magnetic Resonance Images (MRI) like the hippocampus, lateral ventricles, and brain lobes in the standard report.
  • Automated generation of patient reports that clinicians can use as a tool to guide clinical decision-making.
  • Computes a report of the most important structures in the brain in less than 10 minutes.
  • The Neuroreader is customizable and can be tailored to the customer’s specific needs.
brainreader-q92kj1lxx5ite8a2r0s9sishv46cfpnixlq5bl0wv6
Neuro-icon-150x150
MRI-icon-1-150x150
FDA-_-CE-icon-150x150

Features

  • Provides an estimation of the normal volume for a person with similar demographics (gender, age, and head size).
  • Longitudinal reports can be plotted over time to detect progression.
  • Brain volume assessment table with 64 volumes (measured in mL, percentiles, z-score, and more) in the standard report (83 brain volumes in the customizable report).
  • Brain heat maps visualization tool that shows the percentile values and area/s of concern.
  • Values and statistics of the Left-Right Asymmetry Index (13 brain structures).
  • Disease specific reports: Asymmetry and Neurodegenerative reports are available.
  • Original and segmented 3D images in NIfTI and DICOM formats:
    • Combined Classification  
    • Filtered Combined Labels  
    • Intracranial  
    • Exportable JSON values of the results for research purposes

Benefits

  • Monitors the effectiveness of treatments and interventions over time. By comparing follow-up scans with baseline measurements, clinicians can evaluate the impact of therapies on brain volume changes.
  • Objectively analyzes by comparing volumes against large and diversified normative datasets.
  • Helps clinicians discover and understand early and sensitive biomarkers of neurodegenerative diseases.
  • Eliminates bias and subjectivity and gives an answer to the exact degree of atrophy.
  • Neuroreader® reduces read times from approximately 24 to 10 minutes, which ultimately means 14 minutes per scan. (1) 

Image examples

Explore Neuroreader® through our video case studies, highlighting how our software detects abnormal brain patterns in MRI scans.

To find out more about Brainreader’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting

(1) White paper: Neuroreader® Brain Volumetric Report reduces time to diagnosis [Internet]. [cited 2023 Aug 17].